Intuitive Surgical price target raised to $616 from $589 at BTIG

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $616 from $589 and keeps a Buy rating on the shares. Analysis of the Dv5 launch suggests its value extends beyond higher system average selling prices, with the growing install base also driving incremental I&A revenue through increased utilization and new procedures, the analyst tells investors in a research note. Based on management commentary and Street assumptions, Dv5 is estimated to account for about 25% of modeled FY26 revenue growth and roughly 35% in FY27, with its impact better understood by examining contributions across both System and I&A revenue rather than topline alone, the firm says.